Peter L. Hoang - Net Worth and Insider Trading
Peter L. Hoang Net Worth
The estimated net worth of Peter L. Hoang is at least $123,716 dollars as of 2024-11-13. Peter L. Hoang is the President and CEO of Marker Therapeutics Inc and owns about 33,257 shares of Marker Therapeutics Inc (MRKR) stock worth over $123,716. Details can be seen in Peter L. Hoang's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peter L. Hoang has not made any transactions after 2021-03-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peter L. Hoang
Peter L. Hoang Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peter L. Hoang owns 2 companies in total, including Marker Therapeutics Inc (MRKR) , and Bellicum Pharmaceuticals Inc (BLCM) .
Click here to see the complete history of Peter L. Hoang’s form 4 insider trades.
Insider Ownership Summary of Peter L. Hoang
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
MRKR | Marker Therapeutics Inc | 2021-03-16 | director & CEO and President |
BLCM | Bellicum Pharmaceuticals Inc | 2014-12-17 | Sr. VP of Bus. Development |
Peter L. Hoang Latest Holdings Summary
Peter L. Hoang currently owns a total of 1 stock. Peter L. Hoang owns 33,257 shares of Marker Therapeutics Inc (MRKR) as of March 16, 2021, with a value of $123,716.
Latest Holdings of Peter L. Hoang
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MRKR | Marker Therapeutics Inc | 2021-03-16 | 33,257 | 3.72 | 123,716 |
Holding Weightings of Peter L. Hoang
Peter L. Hoang Form 4 Trading Tracker
According to the SEC Form 4 filings, Peter L. Hoang has made a total of 1 transactions in Marker Therapeutics Inc (MRKR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Marker Therapeutics Inc is the acquisition of 14,286 shares on March 16, 2021, which cost Peter L. Hoang around $250,000.
Insider Trading History of Peter L. Hoang
- 1
Peter L. Hoang Trading Performance
GuruFocus tracks the stock performance after each of Peter L. Hoang's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peter L. Hoang is 18.27%. GuruFocus also compares Peter L. Hoang's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peter L. Hoang within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peter L. Hoang's insider trading performs compared to the benchmark.
Performance of Peter L. Hoang
Peter L. Hoang Ownership Network
Ownership Network List of Peter L. Hoang
Ownership Network Relation of Peter L. Hoang
Peter L. Hoang Owned Company Details
What does Marker Therapeutics Inc do?
Who are the key executives at Marker Therapeutics Inc?
Peter L. Hoang is the director & CEO and President of Marker Therapeutics Inc. Other key executives at Marker Therapeutics Inc include Interim CFO Eliot M Lurier , 10 percent owner Mohamad Makhzoumi , and 10 percent owner Carmen Chang .
Marker Therapeutics Inc (MRKR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Marker Therapeutics Inc (MRKR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Marker Therapeutics Inc (MRKR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Marker Therapeutics Inc (MRKR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Marker Therapeutics Inc Insider Transactions
Peter L. Hoang Mailing Address
Above is the net worth, insider trading, and ownership report for Peter L. Hoang. You might contact Peter L. Hoang via mailing address: C/o Bellicum Pharmaceuticals, Inc., 2130 W. Holcombe Blvd., Ste. 800, Houston Tx 77030.